Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "operations"

1231 News Found

Eli Lilly appoints Chandan S. as Senior Director for Data Science and AI Engineering
People | May 22, 2026

Eli Lilly appoints Chandan S. as Senior Director for Data Science and AI Engineering

AI and analytics leader brings extensive expertise in machine learning, GenAI, and life sciences decision intelligence to Lilly’s data science operations


APHI welcomes CCI order on integrated healthcare delivery model
Healthcare | May 22, 2026

APHI welcomes CCI order on integrated healthcare delivery model

The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices


Dr. Amit Arora joins Curelo as Co-founder & COO
People | May 22, 2026

Dr. Amit Arora joins Curelo as Co-founder & COO

Diagnostic-guided healthcare platform strengthens leadership team to accelerate AI-driven diagnostics and consumer healthcare expansion


Aurobindo Pharma Q4 FY26 revenue rises 5.6% to Rs. 8,853 crore
News | May 22, 2026

Aurobindo Pharma Q4 FY26 revenue rises 5.6% to Rs. 8,853 crore

Net profit stood at Rs. 921 crore for the quarter, while Europe revenues surged 30.2% YoY to Rs. 2,795 crore


Dr. Agarwal’s crosses Rs. 2,000 crore revenue milestone in FY26
Hospitals | May 22, 2026

Dr. Agarwal’s crosses Rs. 2,000 crore revenue milestone in FY26

Eye care major expands network to 288 facilities across 10 countries after adding 57 new centres during FY26


Jubilant Pharmova posts 14% FY26 revenue growth to Rs. 8,280 crore amid margin pressure
News | May 22, 2026

Jubilant Pharmova posts 14% FY26 revenue growth to Rs. 8,280 crore amid margin pressure

Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum


IOLCP revenue rises 11.5% YoY to Rs. 2,319.1 crore in FY26
News | May 21, 2026

IOLCP revenue rises 11.5% YoY to Rs. 2,319.1 crore in FY26

Company’s EBITDA grew 29.3 per cent to Rs. 290.4 crore, while PAT rose 36.4 per cent to Rs. 137.7 crore


Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115 million deal
News | May 21, 2026

Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115 million deal

SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization


ZenMD launches India-focused clinical AI platform for doctors and hospitals
Digitisation | May 21, 2026

ZenMD launches India-focused clinical AI platform for doctors and hospitals

Solutions designed to help clinicians reduce administrative burden, improve diagnostic accuracy, and spend more time with patients


Bristol Myers Squibb & Anthropic redraw biopharma with Claude-powered enterprise AI
Digitisation | May 21, 2026

Bristol Myers Squibb & Anthropic redraw biopharma with Claude-powered enterprise AI

BMS is moving beyond conversational AI into what it describes as “agentic” systems